491 related articles for article (PubMed ID: 23542451)
1. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases.
Garby L; Caron P; Claustrat F; Chanson P; Tabarin A; Rohmer V; Arnault G; Bonnet F; Chabre O; Christin-Maitre S; du-Boullay H; Murat A; Nakib I; Sadoul JL; Sassolas G; Claustrat B; Raverot G; Borson-Chazot F;
J Clin Endocrinol Metab; 2012 Jun; 97(6):2093-104. PubMed ID: 22442262
[TBL] [Abstract][Full Text] [Related]
3. Acromegaly caused by growth hormone releasing hormone (GHRH) secreting tumor in multiple endocrine neoplasia (MEN-1).
Saleem TF; Santhanam P; Hamoudeh E; Hassan T; Faiz S
W V Med J; 2012; 108(2):26-30. PubMed ID: 22655432
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
5. Ectopic acromegaly due to a pancreatic neuroendocrine tumor producing growth hormone-releasing hormone.
Weiss DE; Vogel H; Lopes MB; Chang SD; Katznelson L
Endocr Pract; 2011; 17(1):79-84. PubMed ID: 20713338
[TBL] [Abstract][Full Text] [Related]
6. Acromegaly induced by ectopic secretion of GHRH: a review 30 years after GHRH discovery.
Borson-Chazot F; Garby L; Raverot G; Claustrat F; Raverot V; Sassolas G;
Ann Endocrinol (Paris); 2012 Dec; 73(6):497-502. PubMed ID: 23122576
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
8. Acromegaly due to GHRH-secreting large bronchial carcinoid. Complete recovery following tumor surgery.
Bolanowski M; Schopohl J; Marciniak M; Rzeszutko M; Zatonska K; Daroszewski J; Milewicz A; Malczewska J; Badowski R
Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):188-92. PubMed ID: 12058343
[TBL] [Abstract][Full Text] [Related]
9. Ectopic secretion of GHRH by a pancreatic neuroendocrine tumor associated with an empty sella.
Mnif Feki M; Mnif F; Kamoun M; Charfi N; Rekik N; Naceur BB; Mnif L; Boudawara TS; Abid M
Ann Endocrinol (Paris); 2011 Dec; 72(6):522-5. PubMed ID: 21963237
[TBL] [Abstract][Full Text] [Related]
10. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
Cho YY; Chung YJ
Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
[TBL] [Abstract][Full Text] [Related]
11. Acromegaly caused by ectopic growth hormone: a rare manifestation of a bronchial carcinoid.
Biswal S; Srinivasan B; Dutta P; Ranjan P; Vaiphei K; Singh RS; Thingnam SS
Ann Thorac Surg; 2008 Jan; 85(1):330-2. PubMed ID: 18154841
[TBL] [Abstract][Full Text] [Related]
12. A non-acromegalic case of multiple endocrine neoplasia type 1 accompanied by a growth hormone-releasing hormone-producing pancreatic tumor.
Sugihara H; Shibasaki T; Tatsuguchi A; Okajima F; Wakita S; Nakajima Y; Tanimura K; Tamura H; Ishii S; Kamegai J; Akasu H; Kitagawa W; Shimizu K; Nakamura Y; Uchida E; Tajiri T; Naito Z; Katakami H; Oikawa S
J Endocrinol Invest; 2007 May; 30(5):421-7. PubMed ID: 17598976
[TBL] [Abstract][Full Text] [Related]
13. [Clinical symptoms, diagnosis and treatment of multiple endocrine neoplasia type 1. Results of genetic screening in Hungarian patients].
Balogh K; Hunyady L; Patócs A; Valkusz Z; Bertalan R; Gergics P; Majnik J; Toke J; Tóth M; Szucs N; Gláz E; Futo L; Horányi J; Rácz K; Tulassay Z
Orv Hetil; 2005 Oct; 146(43):2191-7. PubMed ID: 16323565
[TBL] [Abstract][Full Text] [Related]
14. [Five year remission of GHRH secreting bronchial neuroendocrine tumor with symptoms of acromegaly. Utility of chromogranin A in the monitoring of the disease].
Bolanowski M; Kos-Kudła B; Rzeszutko M; Marciniak M; Zatońska K
Endokrynol Pol; 2006; 57(1):32-6. PubMed ID: 16575760
[TBL] [Abstract][Full Text] [Related]
15. Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.
van Hoek M; Hofland LJ; de Rijke YB; van Nederveen FH; de Krijger RR; van Koetsveld PM; Lamberts SW; van der Lely AJ; de Herder WW; Feelders RA
J Clin Endocrinol Metab; 2009 Feb; 94(2):428-33. PubMed ID: 19017754
[TBL] [Abstract][Full Text] [Related]
16. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.
Fainstein Day P; Frohman L; Garcia Rivello H; Reubi JC; Sevlever G; Glerean M; Fernandez Gianotti T; Pietrani M; Rabadan A; Racioppi S; Bidlingmaier M
Pituitary; 2007; 10(3):311-9. PubMed ID: 17373589
[TBL] [Abstract][Full Text] [Related]
17. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
18. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).
Turner JJ; Christie PT; Pearce SH; Turnpenny PD; Thakker RV
Hum Mutat; 2010 Jan; 31(1):E1089-101. PubMed ID: 19953642
[TBL] [Abstract][Full Text] [Related]
20. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
